InterOcean Capital Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.24M | Sell |
13,116
-50,815
| -79% | -$4.82M | 0.03% | 183 |
|
|
2023
Q4 | $5.71M | Sell |
63,931
-236
| -0.4% | -$21.1K | 0.15% | 95 |
|
|
2023
Q3 | $4.69M | Sell |
64,167
-208,379
| -76% | -$15.2M | 0.14% | 96 |
|
|
2023
Q2 | $22.7M | Sell |
272,546
-10,146
| -4% | -$844K | 0.71% | 38 |
|
|
2023
Q1 | $21.5M | Buy |
282,692
+21,171
| +8% | +$1.61M | 0.73% | 39 |
|
|
2022
Q4 | $21.7M | Sell |
261,521
-5,476
| -2% | -$455K | 0.79% | 38 |
|
|
2022
Q3 | $21.2M | Buy |
266,997
+10,229
| +4% | +$811K | 0.87% | 37 |
|
|
2022
Q2 | $19.1M | Buy |
256,768
+25,345
| +11% | +$1.88M | 0.78% | 41 |
|
|
2022
Q1 | $20.8M | Buy |
231,423
+15,421
| +7% | +$1.39M | 0.89% | 38 |
|
|
2021
Q4 | $24.2M | Buy |
216,002
+23,860
| +12% | +$2.67M | 1.05% | 32 |
|
|
2021
Q3 | $24.2M | Buy |
192,142
+79,612
| +71% | +$10M | 1.21% | 29 |
|
|
2021
Q2 | $15.2M | Buy |
112,530
+106,670
| +1,820% | +$14.4M | 0.78% | 37 |
|
|
2021
Q1 | $795K | Buy |
5,860
+1,180
| +25% | +$160K | 0.04% | 123 |
|
|
2020
Q4 | $659K | Buy |
+4,680
| New | +$659K | 0.04% | 116 |
|